Task Force staffer quits over screening controversy; New biomarker for early-stage diabetes;

> A support staffer for the U.S. Preventive Services Task Force resigned after a key meeting was canceled to review a move to recommend against prostate cancer screening for all ages. Dr. Kenneth Lin said that "politics trumped science," noting that the group was looking to avoid any election-day controversy similar to the one that erupted over recent recommendations on screening for breast cancer. Story

> Sophic Systems Alliance won a $750,000 SBIR grant to create a one-stop shop for cancer biomarkers. Report

> In a proteomics study of serum from rats treated with diabetogenic virus, a research team utilized 2D gel analysis and mass spectrometry and found increased levels of serum haptoglobin very early in the time course of diabetes induction. Release

> Pacific Biomarkers was included on Deloitte's recent report on the Fast 500 tech companies in the U.S. Pacific release

> Flagship Biosciences announced the launch of a new tissue biomarker multiplexing analytical tool for tumors and other tissues. Flagship release

And Finally... The Top Writers in Biotech. Report

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.